Literature DB >> 17106803

Haemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus casei.

Débora Colombi1, Maria L S Oliveira, Ivana B Campos, Vicente Monedero, Gaspar Pérez-Martinez, Paulo L Ho.   

Abstract

Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella pertussis related to the adhesion and spread of the bacteria through the respiratory tract. Three distinct domains have been characterized in mature FHA, and among them, the FHA(442-863) fragment was suggested to be responsible for the heparin-binding activity. In this study, we cloned the gene encoding the HEP fragment (FHA(430-873)) in a Lactobacillus casei-inducible expression vector based on the lactose operon. The recombinant bacteria, transformed with the resulting construct (L. casei-HEP), were able to express the heterologous protein depending on the sugar added to the culture. Subcutaneous inoculation of L. casei-HEP in Balb/C mice, using the cholera toxin B subunit as adjuvant, induced systemic anti-HEP antibodies that were able to inhibit in vitro erythrocyte haemagglutination induced by FHA. This is the first example of a B. pertussis antigen produced in lactic acid bacteria and opens new perspectives for alternative vaccine strategies against whooping cough.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106803     DOI: 10.1007/s00284-005-0388-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  12 in total

1.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model.

Authors:  Mineo Watanabe; Eiji Komatsu; Katsuyo Abe; Shigeharu Iyama; Takaaki Sato; Masaaki Nagai
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

Review 3.  Potential and opportunities for use of recombinant lactic acid bacteria in human health.

Authors:  Sean Hanniffy; Ursula Wiedermann; Andreas Repa; Annick Mercenier; Catherine Daniel; Jean Fioramonti; Helena Tlaskolova; Hana Kozakova; Hans Israelsen; Søren Madsen; Astrid Vrang; Pascal Hols; Jean Delcour; Peter Bron; Michiel Kleerebezem; Jerry Wells
Journal:  Adv Appl Microbiol       Date:  2004       Impact factor: 5.086

4.  Incompatibility of Lactobacillus Vectors with Replicons Derived from Small Cryptic Lactobacillus Plasmids and Segregational Instability of the Introduced Vectors.

Authors:  M Posno; R J Leer; N van Luijk; M J F van Giezen; P T H M Heuvelmans; B C Lokman; P H Pouwels
Journal:  Appl Environ Microbiol       Date:  1991-06       Impact factor: 4.792

5.  Elements involved in catabolite repression and substrate induction of the lactose operon in Lactobacillus casei.

Authors:  M J Gosalbes; V Monedero; G Pérez-Martínez
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

6.  Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors:  P Olin; F Rasmussen; L Gustafsson; H O Hallander; H Heijbel
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

7.  Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.

Authors:  Ana Paula Mattos Arêas; Maria Leonor Sarno Oliveira; Eliane Namie Miyaji; Luciana Cezar Cerqueira Leite; Karina Araújo Aires; Waldely Oliveira Dias; Paulo Lee Ho
Journal:  Biochem Biophys Res Commun       Date:  2004-08-13       Impact factor: 3.575

8.  Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.

Authors:  D R Wilson; A Siebers; B B Finlay
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

9.  Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

Authors:  C Grangette; H Müller-Alouf; D Goudercourt; M C Geoffroy; M Turneer; A Mercenier
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.

Authors:  Maria Leonor Sarno Oliveira; Ana Paula Mattos Arêas; Ivana Barros Campos; Vicente Monedero; Gaspar Perez-Martínez; Eliane Namie Miyaji; Luciana Cezar Cerqueira Leite; Karina Araújo Aires; Paulo Lee Ho
Journal:  Microbes Infect       Date:  2006-01-18       Impact factor: 2.700

View more
  6 in total

1.  Role of HrpA in biofilm formation of Neisseria meningitidis and regulation of the hrpBAS transcripts.

Authors:  R Brock Neil; Michael A Apicella
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

Review 2.  The versatility and adaptation of bacteria from the genus Stenotrophomonas.

Authors:  Robert P Ryan; Sebastien Monchy; Massimiliano Cardinale; Safiyh Taghavi; Lisa Crossman; Matthew B Avison; Gabriele Berg; Daniel van der Lelie; J Maxwell Dow
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

3.  Double-Face Meets the Bacterial World: The Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Felipe Lira; Gabriele Berg; José L Martínez
Journal:  Front Microbiol       Date:  2017-11-09       Impact factor: 5.640

4.  The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.

Authors:  Lisa C Crossman; Virginia C Gould; J Maxwell Dow; Georgios S Vernikos; Aki Okazaki; Mohammed Sebaihia; David Saunders; Claire Arrowsmith; Tim Carver; Nicholas Peters; Ellen Adlem; Arnaud Kerhornou; Angela Lord; Lee Murphy; Katharine Seeger; Robert Squares; Simon Rutter; Michael A Quail; Mari-Adele Rajandream; David Harris; Carol Churcher; Stephen D Bentley; Julian Parkhill; Nicholas R Thomson; Matthew B Avison
Journal:  Genome Biol       Date:  2008-04-17       Impact factor: 13.583

Review 5.  Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens.

Authors:  Jonathan S LeCureux; Gregg A Dean
Journal:  mSphere       Date:  2018-05-16       Impact factor: 4.389

Review 6.  Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines.

Authors:  Allison C Vilander; Gregg A Dean
Journal:  Vaccines (Basel)       Date:  2019-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.